Herantis Pharma Oyj (HRTIS) — Capital Reinvestment Ratio

Latest as of December 2013: 2299.45x

Herantis Pharma Oyj (HRTIS) has a Capital Reinvestment Ratio of 2299.45x as of December 2013, meaning it reinvests 2299% of its operating cash flow (€183.24) in capital expenditures (€421.35K). See Herantis Pharma Oyj balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

2299.45x

Capex / Operating Cash Flow

Operating Cash Flow

€183.24

EUR

Capital Expenditures

€421.35K

EUR

Data as of

Dec 2013

Most recent filing

Annual Capital Reinvestment Ratio for Herantis Pharma Oyj (None–None)

Year-by-year Capital Reinvestment Ratio for Herantis Pharma Oyj from None to None. For live market cap and broader valuation context, see HRTIS stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow